Current Studies and Clinical Trials

The UnionDerm research team is currently engaged in multiple cutting-edge trials and studies. If you are interested in participating in one of our studies, please scroll down to the “Participating in Future Studies” section at the bottom of this page to learn more.

 

We are currently recruiting for:

1. Radiofrequency Device for Treatment of Facial Wrinkles
We are currently conducting a clinical research study evaluating the XERF device, a non-invasive radiofrequency treatment being studied for its effect on facial wrinkles.

Some basic eligibility criteria include:

  • Bothered by the appearance of facial wrinkles or fine lines
  • No energy-based skin treatments (e.g., laser resurfacing, RF treatments, chemical peels) in the past 6 months
  • No neurotoxin injections (e.g., Botox) or non-permanent fillers in the past 6 months
  • No pacemaker, defibrillator, or other implanted electrical/metal device
  • Non-smoker or have not smoked within the past month

Final eligibility will be determined during a screening visit. If you are interested in participating or would like to learn more, please contact our research team at research@unionderm.com to see if you may qualify.

2. A treatment for hair loss in Skin of Color patients using the Folix laser system

  • We are recruiting male and female patients between 21 – 55 years of age with Fitzpatrick skin types 5 & 6 who are seeking treatment for hair loss and hair thinning. Since this treatment has been FDA-approved to safely and effectively improve hair loss in skin types 1 – 4, this study’s purpose is to confirm these results in subjects with darker skin types (5 – 6) who have not used other hair growth treatments in the past 90 days. After confirming qualification at the screening visit, participants will receive 4 treatments, spaced 4 weeks apart, and will return for follow-up visits 1 month and 3 months post their last treatment to assess the results (total: 7 visits). You will be compensated $75 for visit and $100 for each follow-up visit, for a total of $575 upon study completion.

 

Upcoming studies are listed below. Please note that the studies below are not yet open for enrollment. Contact our research team to express your interest and be added to the contact list.

1. Males and females between 18 to 64 years of age who are seeking treatment for the appearance of abdominal fat. Must have a BMI greater than 18.5 and less than 30 kg/m^2, and weight greater than or equal to 50 kg (110.2 lbs) to qualify.

* You may not be eligible to participate if any of the following apply:

  • On weight reduction medication, weight reduction programs, or GLP-1 within the past 6 months
  • Has a diagnosis of coagulation disorders or is receiving anticoagulant/antiplatelet therapy
  • Has active or prior history of malignancies in the past 5 years or is currently being evaluated for a possible malignancy
  • Has ventral abdominal or umbilical hernia or has had repairs
  • Has undergone the following procedures:
      • Previous surgery that caused scar tissue in the treatment area (exceptions: laparoscopic surgery)
      • Abdominoplasty or liposuction to the treatment area
      • Body contouring or fat reduction procedures in the past 12 months
      • Has used medication that is delivered via subcutaneous injection to the treatment area in the past 4 weeks
  • Is undergoing chronic systemic steroid or immunosuppressive therapy
  • Has liver cirrhosis, inadequate liver function, or any renal impairment

 

PARTICIPATING IN FUTURE STUDIES

Study participants receive study-related exams, lab tests, and the investigational study medication or treatment at no charge. Additionally, participants are typically compensated for their time by the study sponsor.

For more information about participating in clinical trials at UnionDerm, please call us at (212) 366-5400 or email us at research@unionderm.com. Please specify which study you are interested in.

How can we help you?

Follow us on Instagram

@unionderm